Learn how to manage hereditary angioedema (HAE) attacks with on-demand medications, from identifying early symptoms to ...

Roche was granted a Phase 3 clinical trial waiver by CDSCO last year for the Indian launch of Tecentriq SC. The Swiss pharma ...

The approval covers all 27 EU member states, Liechtenstein, Norway, and Iceland.

Tecentriq SC, launched in India by the pharma giant Roche, is subcutaneous. This means it is injected directly under the skin ...

COYA 302, an injection therapy in development for the treatment of ALS, has been awarded fast track status by the U.S. Food and Drug Administration. The therapy aims to slow ALS progression by ...

The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.

In less than a month , South Africa will start rolling out the most potent HIV prevention medication the world has seen. But ...

When a baby is born, hospital staff move quickly through a standard checklist of newborn care: taking measurements, ...

The treatment, now being offered at Royal Cornwall Hospitals NHS Trust (RCHT), is an injectable form of pembrolizumab (Keytruda).

Cancer patients and their caretakers in India often spend long, arduous hours in hospitals for conventional treatment.But now with the launch of the ...

Allies of the ex-health secretary say the next leader should be elected in a 'broad' contest to have the most legitimacy ...

Bank of America's Annual Healthcare Conference in very toasty Las Vegas. I'm very happy to be joined here on stage with Carl Hansen with AbCellera. Thank you so much for joining. Sure. So the company ...